Skip to content

Drug interactions

Ibrutinib + Nicardipine

Severity: Moderate

Ibrutinib and Nicardipine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nicardipine may raise ibrutinib exposure through CYP3A4 inhibition, increasing the risk of bleeding, arrhythmias, and cytopenias. The effect is smaller than with strong inhibitors.

What this interaction means in plain words

Ibrutinib and Nicardipine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ibrutinib belongs to Oncology; Nicardipine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 reduces ibrutinib's extensive first-pass and systemic metabolism.

What to do

Monitor for ibrutinib toxicity including bleeding, atrial fibrillation, and hypertension. Reduce the ibrutinib dose per labeling for moderate CYP3A4 inhibitors if adverse effects occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ibrutinib and Nicardipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ibrutinib with Nicardipine?

MediHelp rates the interaction as moderate. Ibrutinib and Nicardipine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nicardipine may raise ibrutinib exposure through CYP3A4 inhibition, increasing the risk of bleeding, arrhythmias, and cytopenias. The effect is smaller than with strong inhibitors.

How serious is the interaction between Ibrutinib and Nicardipine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ibrutinib toxicity including bleeding, atrial fibrillation, and hypertension. Reduce the ibrutinib dose per labeling for moderate CYP3A4 inhibitors if adverse effects occur.

What other medicines interact with Nicardipine?

MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in